SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-14-048026
Filing Date
2014-07-17
Accepted
2014-07-17 20:52:55
Documents
1
Period of Report
2014-07-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4014
  Complete submission text file 0001209191-14-048026.txt   5684
Mailing Address 699 BOYLSTON ST 11TH FLOOR BOSTON MA 02116
Business Address 699 BOYLSTON ST 11TH FLOOR BOSTON MA 02116 617-600-4164
EPIRUS Biopharmaceuticals, Inc. (Issuer) CIK: 0001135906 (see all company filings)

IRS No.: 043514457 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O EPIRUS BIOPHARMACEUTICALS, INC. 399 BOYLSTON ST., 11TH FL BOSTON MA 02116
Business Address
Ticktin Robert (Reporting) CIK: 0001613482 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-51171 | Film No.: 14981566